Results 221 to 230 of about 38,480 (291)

Reversibility of Apixaban Anticoagulation with a Four‐Factor Prothrombin Complex Concentrate in Healthy Volunteers

open access: gold, 2016
Srinivasa R. Nagalla   +5 more
openalex   +1 more source

REAL WORLD COMPARISON OF MAJOR BLEEDING RISK AMONG NON-VALVULAR ATRIAL FIBRILLATION PATIENTS NEWLY INITIATED ON APIXABAN, WARFARIN, DABIGATRAN OR RIVAROXABAN: A 1:1 PROPENSITY-SCORE MATCHED ANALYSIS

open access: bronze, 2016
Gregory Y.H. Lip   +8 more
openalex   +1 more source

Apixaban outcomes in atrial fibrillation patients with a single-dose reduction criterion: ASPIRE 1-year results. [PDF]

open access: yesEur Heart J Cardiovasc Pharmacother
Lee SR   +21 more
europepmc   +1 more source

Trends and Hot Spots in Research Related to Rivaroxaban: Bibliometric Analysis. [PDF]

open access: yesClin Pract
Pawlak K   +3 more
europepmc   +1 more source

THE PHARMACOKINETICS OF APIXABAN IN PATIENTS WITH CARDIOEMBOLIC STROKE IN ACUTE PHASE

open access: diamond, 2016
А. V. Kryukov   +7 more
openalex   +2 more sources

Real-world apixaban concentration in Korean patients with atrial fibrillation. [PDF]

open access: yesBlood Res
Lee SH   +9 more
europepmc   +1 more source

Apixaban Versus Aspirin to Reduce Cognitive Decline After Cryptogenic Stroke and Atrial Cardiopathy: ARCADIA-Cognition Study. [PDF]

open access: yesJ Am Heart Assoc
Lazar RM   +13 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy